On Tuesday, H.C. Wainwright adjusted the price target for Inventiva SA (NASDAQ:IVA) to $13.00, down from the previous $14.00, while maintaining a Buy rating on the stock. This change follows the ...
CVS bought Coram LLC, a drug infusion services provider, for $2.1 billion in 2013. "Providers of infused medications have continued to face a challenging environment for their most highly ...